A team of researchers analyzing Pfizer’s clinical trial data has accused the pharmaceutical giant of concealing deaths during its COVID-19 vaccine trials.
Among the allegations is the failure to disclose the death of a Kansas participant who was part of the BNT162b2 vaccine trial. The death reportedly occurred 41 days after the participant received their second vaccine dose.
The accusations stem from a detailed report led by Dr. Jeyanthi Kunadhasan, an anesthetist and perioperative physician, and a member of the DailyClout research team.
The team alleges that Pfizer’s reporting practices during the critical juncture leading to the FDA’s Emergency Use Authorization (EUA) for the vaccine were flawed, with significant delays in documenting serious adverse events, including deaths. . .
Archive is down at the moment.
Login or register